Sanofi Australia & New Zealand

Sanofi Australia & New Zealand Sanofi Australia & New Zealand is part of Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives.

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions. For further information about Sanofi Australia and New Zealand please visit www.sanofi.com.au. Product Information

Industry regulations do not allow pharmaceutical companies to offer medical advice or guidance to consumers or patients. Consumers should contact their doctor or healthcare professional for advice on medicines or any other health related matter. If you have experienced an adverse event or have a quality concern about a Sanofi product please contact Sanofi’s Medical Information department at medinfo.australia@sanofi.com or call (AU): 1800 818 806. Our medical information service is available between 8am – 6pm AEST weekdays. Community Guidelines

You can review Sanofi Australia and New Zealand’s social media terms of use here: https://www.sanofi.com.au/en/Social-Media-Terms-of-Use

Postings are reviewed by Sanofi and may be removed if they are inappropriate or inconsistent with the intended use of this site. Any comments which mention medicine names, use offensive language, promote commercial interests or are otherwise off-topic, will be removed from the page. We reserve the right to block users who violate the terms of use. Please read Sanofi ANZ privacy policy before using our page: https://www.sanofi.com.au/en/privacy-policy

08/12/2025

1-in-2 people living with severe Chronic Obstructive Pulmonary Disease or experience flare-ups (exacerbations) despite treatment with multiple medications.

Now is the chance to have your say about living with COPD and comment on new medicines that may become available on the Pharmaceutical Benefits Scheme (PBS).

Share your comments online before 21 January: http://spkl.io/6180AcESw

01/12/2025

“I would have been able to plan ahead … and avoid some of the complications I now have from a later diagnosis.” Person living with ( )

Many Australians impacted by wish they had known about the condition before symptoms developed, according to a new report from Breakthrough T1D Australia and Sanofi.

Cost of Not Knowing reveals that, for people impacted by T1D, having their condition detected earlier would have meant being more aware of symptoms and seeking help earlier; more time to understand and learn about T1D; and connecting earlier with the T1D community.

With early detection of T1D now a reality, the report found that 85% of respondents support a national screening program for the autoimmune condition.

Learn more about how early detection could help Australians unknowingly living with early-stage T1D get of this complex autoimmune condition: http://spkl.io/6187AekVv

“The emotional, financial and physical effects were overwhelming to our whole family and continue to this day.” Person l...
27/11/2025

“The emotional, financial and physical effects were overwhelming to our whole family and continue to this day.” Person living with (T1D).

A diagnosis can have a profound impact on almost every aspect of life, according to findings from Cost of Not Knowing, a joint Sanofi and Breakthrough T1D Australia report > http://spkl.io/6186A51Q2.

The report includes insights from people with T1D and their parents, with 86% reporting their emotional and mental wellbeing was affected by a T1D diagnosis; 60% confirming that family financial wellbeing was impacted; and 82% of parents saying they reduced work hours or left the workforce to care for a child with T1D.

also highlights how early detection could help Australians unknowingly living with early-stage T1D get of an earth-shattering diagnosis.

“It was a complete lightning strike out of the blue. You can’t imagine how hard those first few weeks and months are,” N...
26/11/2025

“It was a complete lightning strike out of the blue. You can’t imagine how hard those first few weeks and months are,” Nina, mum to Callum, diagnosed with type 1 diabetes aged 9.

For most Australians diagnosed with ( ), the autoimmune condition arrives without warning.

A survey of people impacted by T1D featured in the Cost of Not Knowing report by Sanofi and T1D Australia discovered that 69% of those diagnosed with T1D had no known family history of the condition. http://spkl.io/6185A51QX

Diagnosis is often sudden and serious, with 84% requiring hospital care and more than half (55%) admitted through an emergency department.

Early detection could help Australians unknowingly living with early-stage T1D get of a sudden and serious diagnosis. To find out more visit http://spkl.io/6182AekO4

Today at Parliament House, Sanofi joined Breakthrough T1D Australia and Hon Mark Butler MP to unveil Cost of Not Knowing...
26/11/2025

Today at Parliament House, Sanofi joined Breakthrough T1D Australia and Hon Mark Butler MP to unveil Cost of Not Knowing – a major report that marks a turning point for ( ) in Australia.

Thanks to decades of research, T1D can now be detected months, or even years, before symptoms appear and insulin is needed; giving families time to prepare and avoid medical emergencies.

Read the Report > http://spkl.io/6180AemAC

18/11/2025

On World COPD Day, spare a thought for the more than half a million Australians living with Chronic Obstructive Pulmonary Disease, a lung condition which can cause life-threatening breathing difficulties.

While is often dismissed as a wheeze or bad cough, it can be a killer disease, landing one Australian in hospital every 10 minutes and claiming more than 7,600 Australian lives each year.

‘Short of Breath, Think COPD’ – this is the theme for this year’s World COPD Day, emphasising that even though COPD is the fourth leading cause of death worldwide, it is often not diagnosed correctly.

COPD is a serious issue in Australia, as a new report on the burden of this lung disease reveals. Published by Evohealth with support from Sanofi, the report highlights timely and correct diagnosis using spirometry testing as key to ensuring optimal care for COPD patients in Australia.

You can read the full report here: http://spkl.io/6183AjRrX

Are you one of the thousands of Australians impacted by Chronic Pulmonary Obstructive Disease ( )?COPD, often known as e...
16/11/2025

Are you one of the thousands of Australians impacted by Chronic Pulmonary Obstructive Disease ( )?

COPD, often known as emphysema or chronic bronchitis, can take a significant toll on patients and carers, affecting every aspect of life.

A new report reveals several shortcomings in how Australia is responding to this common lung condition, which claims more than 7,600 Aussie lives each year.

Proudly supported by Sanofi, the ‘Change that can’t wait: Reducing the human and economic burden of COPD in Australia’ report by health consultancy firm Evohealth provides practical recommendations to ensure improved management and quality of life for people living with COPD.

Have a look at the report here: http://spkl.io/6186AjRrY

On , we stand with 412 million working-age adults living with diabetes worldwide.Today, our team in Australia and New Z...
14/11/2025

On , we stand with 412 million working-age adults living with diabetes worldwide.

Today, our team in Australia and New Zealand united to support the International Diabetes Federation's call for more inclusive workplaces where people with diabetes feel supported, not stigmatised. For over 100 years, Sanofi has led innovation in care.

We continue this legacy by:
✨ Partnering with Breakthrough T1D Australia and Diabetes Australia
✨ Collaborating with healthcare professional organisations such as the Australian Diabetes Society and Australian Diabetes Educators Association
✨ Learning from leading Australian

Together, we can create environments where people with diabetes thrive without compromising their health or ambitions.

07/11/2025

Protecting people from preventable diseases like is part of our mission at Sanofi.

That’s why we’re getting behind as a timely reminder that you can become seriously ill with pertussis (commonly known as whooping cough) and are at increased risk of hospitalisation from this and other infectious respiratory diseases.

In this video, Heidi recalls how a recent case of whooping cough left her gasping for breath. Research shows each person infected with whooping cough can pass it on to five unvaccinated people, which may include infants.

Visit http://spkl.io/6180AwALu for more information or talk to your doctor about protection against whooping cough and other infectious respiratory diseases.

07/11/2025

We Volunteer-ed 🤝 Throughout October, Team Sanofi contributed over 400 volunteer hours to support our local communities and environment.

Sanofians across Australia partnered with Foodbank NSW & ACT FareShare OzHarvest Queensland Clean Up Australia and Vinnies NSW to make a real difference:
🥗 Addressing food insecurity through food donation, sorting and meal preparation
🌟 Supporting Vinnies' end-of-year outreach program
🌿 Cleaning up the banks of Parramatta River

As Luke, our Head of Corporate Affairs says: "As a healthcare company we know our responsibility extends beyond delivering innovative medicines, to being an active corporate citizen in the communities we serve."

This initiative is part of our broader commitment to sustainability and community engagement. While we chase the miracles of science, we're also dedicated to creating positive impact right here in our local communities and improving people’s lives. Go team!

😣 One Australian is admitted to hospital every 10 minutes.💔 More than 7,600 Australian lives are claimed each year.📈 $1....
30/10/2025

😣 One Australian is admitted to hospital every 10 minutes.
💔 More than 7,600 Australian lives are claimed each year.
📈 $1.67 billion cost to the Australian healthcare system.

These are some of the key figures unveiled in Australian Parliament House today during the launch of a new report on the burden of Chronic Obstructive Pulmonary Disease ( ) in Australia.

Many people haven’t heard of COPD, while some will know the condition as emphysema or chronic bronchitis.

Yet COPD is a seriously debilitating lung disease that makes it hard to breathe. Without effective management, it worsens with time, causing chest infections and lung damage.

The ‘Change that can’t wait: Reducing the human and economic burden of COPD in Australia’ report aims to prevent this irreversible damage for the 500,000+ Australians currently living with COPD. Developed by Evohealth with support from Sanofi Australia, the report offers concrete recommendations to reduce the burden of COPD on patients, families, and our healthcare system.

With the lung condition expected to affect more than 840,000 Australians by 2050, now is the time to implement these recommendations and help turn the tide.

Thank you Mark Brooke, CEO of Lung Foundation Australia, Dr Sanjay Ramakrishnan and Renae Beardmore for offering such valuable insights and advocating for the change that can’t wait.

You can read the report here: http://spkl.io/6188AZjFr

Address

D/12-24 Talavera Road, Macquarie Park
Sydney, NSW
2113

Telephone

+61286662000

Website

Alerts

Be the first to know and let us send you an email when Sanofi Australia & New Zealand posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sanofi Australia & New Zealand:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category